10/29/2026
In July, an FDA advisory panel recommended six peptides for compounding. This week, HHS took the next step.
The HHS is now easing access to compound BPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semax by prescription, under strict sourcing and quality conditions, while the FDA finalizes its rules.
What hasn’t changed for us: every peptide we prescribe comes from a licensed, US-based 503A pharmacy with a certificate of analysis and verified lot purity, and every prescription starts with labs and a provider consult.
What’s new: our peptide therapy is now available through telemedicine in every state where we’re licensed. That means more people can get peptides prescribed by a provider and filled by a regulated pharmacy, instead of buying unverified vials online, where there’s no guarantee of what’s actually inside.
Questions about whether peptide therapy is right for you?
📲 Call or Text our offices:
Orlando, FL (407)233-4006
Pittsburgh, PA (412) 615-3804
Ebensburg, PA (814) 208-8001